Topic Archives: Curzio Research Advisory

Just got spammed by Curzio: Rare Small Cap Recommendation (less than 2 bill?) Biggest Growth Sectors in America (construction?) Growing Faster than peers (done a ton of acquistioons) CEO recently bought $1 million of stock (new CEO just bought) Might be SUM which seems to tick all the boxes, but don’t know for sure.

Got a Curzio spam the other day touting his newest CVA newsletter pick: And my newest pick could be the best-performing one of them all…It’s an under-the-radar biotech that recently applied for an FDA emergency use authorization. That’s when the government allows a healthcare product to be sold without having to go through the entire […]

I’ll let you know up front that this is not a particularly “secret” stock reveal today — yes, Frank Curzio is hinting at a stock to promote his entry-level newsletter (Curzio Research Opportunities, currently $49), but you could find this stock on your own. Anyone could, that’s the nature of a unique product. But I’ve […]

Curzio Research Advisory still e-mails me cover letters for their picks, where they don’t disclose their picks. Last month, I think it had to be KSS. I can’t tell for sure because I’ve been locked out of the system since I refused to pay his $35 ”maintenance” fee on my ”lifetime membership” a couple of […]

Frank Curzio’s latest ad for his Curzio Research Advisory newsletter ($79/yr) starts out with a pretty big promise… “There’s a one-in-three chance someone you know could be saved by this new device. “That’s because one in three Americans will die due to cardiovascular disease – the No.1 killer not only in America, but worldwide.” And […]

Frank Curzio has graced the pages of Gumshoe quite a few times over the years, under the aegis of several different publishers, but this is the first time he has actively promoted his new self-published “front end” newsletter, Curzio Research Advisory (he launched his “back end” newsletter, Curzio Venture Opportunities, late last year). I don’t […]

Comments

No comments.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info